Introduction {#sec1}
============

Direct sp^2^ C--H metallation^[@ref1]−[@ref8]^ is an active area of research because it can be used for efficient functionalization of arenes without the use of specially designed, halogenated, and/or hazardous precursors. In general, sp^2^ C--H activation of arenes requires high temperatures, which greatly hampers achieving the desired selectivity and obtaining thermally labile compounds such as valuable sugar-based chiral compounds. Thus, activating an sp^2^ C--H bond, especially in electron-rich arenes such as anilines,^[@ref9]−[@ref13]^ under mild conditions is desirable and will open up new opportunities toward the selective construction of ubiquitous heterocycles such as quinolines and their valuable chiral analogues through multicomponent^[@ref14]−[@ref16]^ domino cyclization^[@ref17]−[@ref23]^ reactions. In this regard, we envisaged the development and exploitation of a new Cu^I^--Cu^III^ switching catalysis^[@ref24]−[@ref30]^ under mild conditions, which would efficiently deliver C--H-activated C--C/C--X bonds to form functional groups with tandem cyclization toward an unprecedented general synthesis of quinolones, with an improved reaction rate, selectivity, and substrate scope. The mechanisms of the widely used catalysis with Cu^I^-compounds^[@ref24]−[@ref35]^ that pass through a Cu^I^--Cu^III^ transition have not been thoroughly investigated. The scope of the reported C--H metallation through a Cu^I^--Cu^III^ transition^[@ref31]−[@ref35]^ is also limited because of high temperatures and/or stringent reaction conditions.

Chirality plays a pivotal role in the lives of plants and animals, such as in biochemical transformations and the functioning of drugs.^[@ref36]−[@ref38]^ Naturally occurring chiral cinchona alkaloids bearing a quinoline motif and other chiral analogues are used as "lead" and antimalarial drugs, chiral architecture for materials, and asymmetric catalysts.^[@ref39]−[@ref43]^ Sugar-based chiral quinolines have recently been used as a new antioxidant modulator for amyloid aggregation, an Hg^2+^-sensor, and potent antimicrobial, antituberculosis, and DNA-intercalating antitumor agents (A--E, [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).^[@ref44]−[@ref48]^ In light of the diverse applications of chiral quinolines, a few methods have been developed for their preparation: Friedländer condensation using costly precursors consisting of β-*C*-glycosidic ketones and 2-aminobenzaldehyde derivatives to form methylene-bridged sugar quinolines upon heating in the presence of pyrrolidine (25 mol %),^[@ref45]^ Cu^I^-catalyzed sugar-based alkyne--azide quinoline cycloaddition to 1,2,3-triazole-bridged chiral quinolines,^[@ref46]^ and PPh~3~AuCl (10 mol %)--AgSbF~6~ (10 mol %)-catalyzed propargyl sugar aldehyde and aniline cycloaddition to quinoline-pyrano-fused sugars,^[@ref47]^ as well as a few other methods.^[@ref48]^ Quinolines directly attached to the chiral centers such as quinine analogues are used in antimalarial and other medical applications. In this regard, sugar molecules directly attached to the quinoline skeleton are potential drug candidates. To the best of our knowledge, synthesis of 2-substituted sugar-based chiral quinolines is unknown in the literature. Thus, the development of a simple and mild strategy toward the direct synthesis of acidic and thermally sensitive 2-substituted sugar-based chiral quinolines will be a valuable addition to the existing modern synthetic approaches to quinolines.

![2-Substituted (A--D) and 2,3-fused (E) bioactive sugar-based quinolines.](ao-2016-00185w_0001){#fig1}

The synthesis of achiral quinolines, such as transition metal-catalyzed cyclization^[@ref49]−[@ref54]^ and alkyne--imine addition reactions,^[@ref55]−[@ref57]^ is well-documented in the literature.^[@ref58]−[@ref63]^ However, instead of making unstable imines through cumbersome approaches, development of an in situ coupling strategy using amines, aldehydes, and terminal alkynes and easy metallation to the *ortho*-sp^2^ C--H through coordination of the triple bond of the in situ-generated flexible propargyl amine (**I**, [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}) moiety will be a valuable addition to the existing methods for the synthesis of chiral quinolines directly attached to sugars under mild conditions. In this context, the combination of two catalysts will be more useful for the direct N--C and C--C coupling of an aldehyde--carbon (**3**) with an amine (**1**) and a terminal alkyne (**2**). Combo-catalysis is an emerging area, and we^[@ref64]−[@ref66]^ and others^[@ref67]−[@ref71]^ have established it as a powerful tool in modern organic synthesis. For instance, the diverse cyclization reactions catalyzed by VO(acac)~2~--CeCl~3~, Ni(0)--Cu(I), and Mo^VI^--CeCl~3~ developed by our group provide easy access to a wide range of heterocycles.^[@ref64]−[@ref66]^ CuBr--ZnI~2~-mediated N--N/C--N coupling for oxidative cyclization,^[@ref67]^ Pd^I^--Ru^I^-mediated Suzuki cross-coupling reactions,^[@ref68]^ AuClL~*n*~--AgSbF~6~-tuned C--C coupled aromatization,^[@ref69]^ Ti--Cr-catalyzed polymerization reactions,^[@ref70]^ and \[IrCuCl~2~\]~2~--AgNTf~2~-guided amination^[@ref71]^ through sp^2^ C--H activation are very useful in the synthesis of combo-catalysis functionalized and sugar-based optically pure quinolines (**4**) under mild reaction conditions, with a significantly improved reaction rate, yield, and selectivity (without **5**). Interestingly, Cu(I/II) compounds^[@ref72]−[@ref77]^ and organozinc(II)^[@ref78]^ were reported as active catalysts for the coupling of secondary aliphatic amines with aldehydes and alkynes with the respective propargyl amines.

![Combo-Catalysis for Mild sp^2^ C--H-Activated Cyclization](ao-2016-00185w_0005){#sch1}

Results and Discussion {#sec2}
======================

After several unsuccessful attempts using potential combo-catalysts^[@ref64]−[@ref71]^ (entries 1--8, [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}), we used ZnI~2~--CuBr (10 mol % each) for the three-component reaction among 2-bromoaniline (**1a**, 1 mmol), 4-ethynyltoluene (**2a**, 1 mmol), and paraformaldehyde (**3a**, 1.2 mmol) in different solvents (entries 9--11, [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}) to achieve the 4-substituted quinoline **4a** at room temperature in 60--65% yield. Gratifyingly, the yield (81%) and the reaction rate (30 min) significantly improved under the solvent-free conditions (entry 12). The combo-catalysis selectively produced **4a**. The possible regioisomer **5a** was not detected. Catalyst loading was optimized \[CuBr (7 mol %)--ZnI~2~ (9 mol %)\] under solvent-free conditions. To understand the role of the counter anion of the combo-catalyst, several experiments were performed with different Zn^II^--Cu^I^-combinations (entries 13--17) under similar reaction conditions, but the reactions were not efficient. Interestingly, when using a higher and more stable oxidation state of copper in CuBr~2~, the reaction was unsuccessful (entry 18). We investigated the reaction with the commonly used sp^2^ C--H activating Pd^II^ and Ru^II^ as well as several other prospective catalysts (entries 19--25), and the results were not encouraging. Interestingly, MoO(acac)~2~ was found to be the alternative to ZnI~2~ (entry 26). However, ZnI~2~ was our cocatalyst of choice because of its low cost and easy availability. The reaction with the nonmetallic Lewis acid cum oxidant PhIO^[@ref78]−[@ref81]^ was unsuccessful because of the complexation and/or oxidation of the aromatic amine (**1a**, entry 27). The reaction was completely blocked in an N~2~ atmosphere, which confirmed the need for aerial oxygen in the construction of quinolines (**4a**, entry 28). However, the yield did not improve when the reaction was performed in an oxygen atmosphere (entry 29).

###### Survey and Optimization of Cyclization Reaction[a](#t1fn1){ref-type="table-fn"}

![](ao-2016-00185w_0008){#GRAPHIC-d88e592-autogenerated}

  entry    metal catalyst[b](#t1fn2){ref-type="table-fn"}         solvent[c](#t1fn3){ref-type="table-fn"}   time (h)   **4a**, yield (%)[d](#t1fn4){ref-type="table-fn"}^,^[e](#t1fn5){ref-type="table-fn"}
  -------- ------------------------------------------------------ ----------------------------------------- ---------- --------------------------------------------------------------------------------------
  1        AgOTf, TiCl~4~                                         CH~2~Cl~2~, rt, air                       24          
  2        V~2~O~5~, CeCl~3~                                      CH~2~Cl~2~, rt, air                       24          
  3        CeCl~3~, AgVO~3~                                       CH~2~Cl~2~, rt, air                       24          
  4        Yb(OTf)~3~, MoO(acac)~2~                               CH~2~Cl~2~, rt, air                       24          
  5        RuCl~3~, Cs~2~CO~3~                                    CH~2~Cl~2~, rt, air                       24          
  6        RuCl~3~, Ag~2~CO~3~                                    CH~2~Cl~2~, rt, air                       24          
  7        \[IrCODCl\]~2~, AgClO~4~                               CH~2~Cl~2~, rt, air                       24          
  8        RhCl~3~, Cu(OTf)~2~                                    CH~2~Cl~2~, rt, air                       24          
  9        ZnI~2~--CuBr                                           CH~2~Cl~2~, rt, air                       4.0        62
  10       ZnI~2~--CuBr                                           PhMe, reflux, air                         4.0        60
  11       ZnI~2~--CuBr                                           THF, reflux, air                          4.0        65
  **12**   **ZnI**~2~**--CuBr**[f](#t1fn6){ref-type="table-fn"}   **rt, air**                               **0.5**    **81**
  13       Zn(OAc)~2~--CuBr                                       rt, air                                   1.5        55
  14       ZnCl~2~--CuBr                                          rt, air                                   1.0        61
  15       ZnI~2~--CuCl                                           rt, air                                   1.0        66
  16       ZnI~2~--CuI                                            rt, air                                   1.0        68
  17       ZnI~2~--CuOTf                                          rt, air                                   2.5        53
  18       ZnI~2~--CuBr~2~                                        rt, air                                   12          
  19       ZnI~2~--FeSO~4~                                        rt, air                                   12         42
  20       ZnI~2~--AgOTf                                          rt, air                                   12         31
  21       ZnI~2~--AuCl                                           rt, air                                   3.0        54
  22       ZnI~2~--PdCl~2~                                        rt, air                                   3.5        45
  23       ZnI~2~--Ru(dppe)Cl~2~                                  rt, air                                   4.0        41
  24       ZnI~2~--PtBr~2~                                        rt, air                                   3.0        48
  25       ZnI~2~--Pd(PPh~3~)~4~                                  rt, air                                   5.0        23
  26       MoO(acac)~2~--CuBr                                     rt, air                                   10         60
  27       PhIO                                                   rt, air                                   4.0         
  28       ZnI~2~--CuBr                                           rt, N~2~                                  24          
  29       ZnI~2~--CuBr                                           rt, O~2~                                  0.4        82

**1a** (1 mmol), **2a** (1 mmol), and **3a** (1.2 mmol).

10 mmol %.

10 mL.

**4a** purified by column chromatography.

**5a** not detected.

Optimum catalyst loading: ZnI~2~ (9 mol %)--CuBr (7 mol %).

Tolerance of various functionalities was successfully screened for this new method ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}) through the synthesis of a large number of valuable 4-substituted quinolines^[@ref82]^ bearing both unsubstituted and substituted aromatic residues ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}), a heterocycle (**4b**, entry 2), a biphenyl system (**4j**, entry 10), and a naphthalene moiety (**4k**, entry 11). Essentially, there was no limitation regarding the substrate choice because the reactions occurred smoothly to produce their respective quinolines on using aromatic amines bearing halogen (**1a--d**, entries 1--4 and 9--17), alkyl (**1e--g** and **1i**, entries 5--7 and 18), and alkoxy (**1h**, entry 8) groups. We initially concentrated on using formaldehyde to derive less substituted quinolines, which found novel applications. Unsubstituted aniline was also effective in the robust cyclization reaction (**1j**, entry 19). Aryl alkynes bearing alkyl, aryl, methoxy, and thiophenyl (**2a--g**) groups were tolerated. An aliphatic alkyne also responded well under the developed reaction conditions (**2h**, entry 12). In general, these simple, mild, and solvent-free products were fully characterized using spectroscopic analyses ([Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.6b00185/suppl_file/ao6b00185_si_001.pdf)). The structure of **4a** was confirmed using single crystal X-ray diffraction analyses ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}),^[@ref83]^ and that of **4h** was confirmed through a comparison with known spectroscopic data.

![Highly Selective Direct Synthesis of Quinolines](ao-2016-00185w_0003){#sch2}

###### Synthesized Quinolines and Reaction Data

![](ao-2016-00185w_0010){#gr9}

![](ao-2016-00185w_0011){#gr8}

The widespread bioactivity and pharmaceutical application of the 2,4-disubstituted quinoline derivatives^[@ref84]−[@ref89]^ led us to investigate their synthesis using the simple combo-catalysis strategy. To our delight, the strategy was equally applicable for aldehydes bearing aliphatic (**3b**, entry 1, [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}) as well as aromatic (**3c--e**, entries 2--4) residues to produce 2,4-disubstituted quinolines (**4t--w**).^[@ref90]^ This mild and solvent-free approach was quite fast (2--3 h) and had good yields (63--74%). Moreover, all of the synthesized products were fully characterized using relevant spectroscopic analyses ([Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.6b00185/suppl_file/ao6b00185_si_002.cif)).

###### List of 2,4-Disubstituted Quinoline Derivatives[a](#t3fn1){ref-type="table-fn"}

![](ao-2016-00185w_0012){#gr10}

ZnI~2~: 9 mol % and CuBr: 7 mol %.

Next, we turned our attention to expanding the scope of the mild tandem cyclization process to achieve valuable sugar-based chiral quinolines. Gratifyingly, the use of glyceraldehydes produced the desired optically pure compound **7a** (eq 1, [Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}) under the developed reaction conditions (entry 12, [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). To understand the versatility of the asymmetric approach, we used different pentose sugar aldehydes (**6b**,**c**; eqs 2 and 3), which produced the desired products **7b**--**d** in 1.5--2.0 h in good yield (63--70%). The scope of the mild combo-catalysis was successfully established for the direct synthesis of functionalized chiral quinolines bearing triose, pentose, and hexose sugar moieties (**7a**--**f**, eqs 1--4) with a rapid reaction rate (1.5--2.0 h) and good yield (63--72%). The optical purity of the quinolines was verified on a semipreparative chiral HPLC column and by measuring the optical rotation.

![One-Step Synthesis of Sugar-Based Chiral Quinolines\
CuBr: 7 mol % and ZnI~2~: 9 mol %.](ao-2016-00185w_0002){#sch3}

Ultraviolet--visible (UV--vis) spectroscopy and X-ray photoelectron spectroscopy (XPS) of the new combo-catalysis process were performed to understand the reaction. A strong absorption band of the reaction mixture (entry 1, [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}) in dry methanol appeared at 529 nm (λ~max~) in the UV--vis spectrum ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}), which is very close to the literature value for the \[aryl-Cu^III^--Br\]Br complex reported by Ribas, Stahl, and colleagues.^[@ref91]^ The XPS spectrum ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}) of the reaction mixture showed the presence of two symbolic peaks at 931.9 and 952.08 eV for Cu^I^ and 933.9 and 953.8 eV for transient Cu^III^.^[@ref92]^

![UV--vis study for the detection of aryl-Cu^III^-species (529 nm).](ao-2016-00185w_0004){#fig2}

![XPS study for detection of Cu^I^--Cu^III^ species.](ao-2016-00185w_0009){#fig3}

To establish the reaction mechanism, we conducted two separate control experiments (**4a**, entry 1, [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}) with CuBr and ZnI~2~, and the reaction did not occur. The cyclization reaction was unsuccessful upon using the imine 2-BrC~6~H~4~--N---CH~2~ and the alkyne **2a** under the reaction conditions (entry 12, [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}), which indicates that the reaction progressed without the formation of an imine intermediate. On the basis of the UV--vis and XPS data, controlled experiments, and literature reports, we propose that Cu^I^ first activates the terminal C--H of the alkyne^[@ref93]^ to produce R--C≡C--Cu (**II**, [Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}). This observation is also supported by the fact that the reaction was completely blocked upon using internal alkynes. The C--C and C--N bond formation between aldehyde (**3**), aromatic amine (**1**), and **II** with ZnI~2~ may give rise to propargyl amine intermediate **III**.^[@ref16]^ The intermediate **III** bearing the flexible C≡C bond allows Cu^I^ to easily activate the aromatic C--H and π-bonds for oxidative C--H insertion with C--C coupling^[@ref94]^ to aryl-Cu^III^-based intermediate (**IV**). The generation of the transient Cu^III^-species was confirmed using UV--vis ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}), XPS ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}), and electrospray ionization mass spectrometry (ESI-MS) (for **IV**; *e*/*z* 441.8867 \[M + H\], appearance of multiple peaks due to the presence of the isotopes of the two Br atoms) analyses of the sample taken from the ongoing reaction (**4a**, entry 1, [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). The seven-membered organometallic compound **IV** immediately transforms into the desired product **4** through the reductive elimination of Cu^I^ and aromatization through the formation of the transient intermediate **V** in the presence of molecular oxygen and CuX.^[@ref95]^ The control experiments for the amine--aldehyde--alkyne coupled cyclization (entries 20 and 21; [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}) were unsuccessful in the absence of air or oxygen. However, the active role of oxygen during the transformation of Cu^I^ to reactive Cu^III^ species may not be avoided.

![Combo-Catalysis Cycle](ao-2016-00185w_0006){#sch4}

Conclusions {#sec3}
===========

In conclusion, a Zn^II^/Cu^I^ combo-catalyzed, solvent-free rapid general synthesis of quinolines was demonstrated through an uncommonly mild, sp^2^ C--H-activated tandem cyclization of anilines--aldehydes--alkynes. The scope of this mild strategy was expanded to the direct synthesis of the widely used 2- and 2,4-disubstituted quinolines and also a new class of valuable chiral quinolines bearing sugar moieties directly attached to the chiral center at the C~2~-position. This method includes a proper example of copper(I)-catalyzed sp^2^ C--H activation and functionalization with in situ-generated aryl copper(III) species. UV--vis, XPS, ESI-MS, and control experiments were successfully carried out to establish the reaction mechanism involving mild Cu^I^--Cu^III^ switching catalysis. This simple and mild combo-catalysis strategy with efficient sp^2^ C--H activation at ambient temperature may create another frontier in the modern synthesis of valuable heterocycles and their chiral analogues.

Experimental Section {#sec4}
====================

General Information {#sec4-1}
-------------------

All reagents were purchased from commercial suppliers and used without further purification, unless otherwise specified. Commercially supplied ethyl acetate and petroleum ether were distilled before use. The petroleum ether used in our experiments had a boiling range of 60--80 °C. Column chromatography was performed on silica gel (60--120 mesh, 0.12--0.25 mm). Analytical thin-layer chromatography (TLC) was performed on 0.25 mm extra-hard silica gel plates with a UV254 fluorescent indicator. The reported melting points are uncorrected. ^1^H NMR and ^13^C NMR spectra were recorded at ambient temperature using 300 MHz spectrometers (300 MHz for ^1^H and 75 MHz for ^13^C). Chemical shifts were reported in parts per million from the tetramethylsilane internal reference, and coupling constants were reported in Hertz. Proton multiplicities were represented as s (singlet), d (doublet), dd (double doublet), t (triplet), q (quartet), and m (multiplet). Infrared spectra were recorded on a Fourier transform infrared (FT-IR) spectrometer in thin films. High-resolution mass spectrometry (HR-MS) data were acquired by electron spray ionization on a Q-ToF-microquadrupole mass spectrometer. Optical rotation of the chiral compounds was measured on a polarimeter using a standard 10 cm quartz cell in a sodium-D lamp at ambient temperature. Electronic absorption spectra were recorded using a UV--vis--NIR spectrophotometer. XPS analyses with the reaction mixture were performed on an XPS instrument.

General Procedure for the Synthesis of Quinolines {#sec4-2}
-------------------------------------------------

A mixture of aromatic amine (**1**, 1 mmol), alkyne (**2**, 1 mmol), aldehyde (**3**, 1.25 mmol), and the metal catalysts ZnI~2~ (9 mol %) and CuBr (7 mol %) together with anhydrous MgSO~4~ was taken in a mortar and thrashed with a pestle for approximately 25--180 min. The progress of the reaction was monitored using TLC. The reaction mixture was extracted with ethyl acetate (25 mL), and the organic layer was washed successively with a saturated sodium bicarbonate solution (1 × 10 mL) and brine (2 × 10 mL). The organic layer was then dried over anhydrous Na~2~SO~4~, filtered, and evaporated in a rotary evaporator under reduced pressure at room temperature. The crude mass was subjected to column chromatography with 5% ethyl acetate--hexane to obtain the corresponding desired product. Thus, the reaction with 2-bromoaniline (**1a**, 1.0 mmol, 177 mg), 4-ethynyltoluene (**2a**, 1.0 mmol, 116 mg), and paraformaldehyde (**3a**, 1.25 mmol, 40 mg) produced 8-bromo-4-*p*-tolylquinoline (**4a**) in 81% yield (240 mg, 0.81 mmol) after purification using column chromatography on silica gel (60--120 mesh) with ethyl acetate--petroleum ether (1:25, v/v) as the eluent. The structure of the product (**4a**) was confirmed using single-crystal X-ray diffractometry. The synthesized quinolines (**4a**--**w**) were characterized using NMR (^1^H and ^13^C), FT-IR, melting point (solid compounds only), and mass spectral (HR-MS) analyses.

Characterization Data of Substituted Quinolines (**4a--w**) {#sec4-3}
-----------------------------------------------------------

### 8-Bromo-4-*p*-tolylquinoline (**4a**) {#sec4-3-1}

Yield: 81% (240 mg, 0.81 mmol). Characteristic: yellow solid. Melting point: 97--98 °C. ^1^H NMR (300 MHz, CDCl~3~): δ 8.99 (1H, d, *J* = 4.5 Hz), 7.99 (1H, d, *J* = 7.5 Hz), 7.87 (1H, d, *J* = 8.5 Hz), 7.07--7.33 (6H, m), 2.38 (3H, s). ^13^C NMR (75 MHz, CDCl~3~): 149.9, 149.3, 144.7, 138.3, 134.0, 132.8, 128.9, 128.8, 127.8, 126.3, 125.6, 124.2, 121.6, 20.7. FT-IR (KBr, cm^--1^): 1604, 1589, 1575, 1484, 1453, 1398, 1383, 783, 754, 731, 709. HR-MS (*m*/*z*) for C~16~H~12~BrN (M^+^): calculated 297.0153, found 297.0155 (one of the major peaks).

### Bromo-6-methyl-4-(thiophen-3-yl)quinoline (**4b**) {#sec4-3-2}

Yield: 80% (243 mg, 0.80 mmol). Characteristic: greenish black solid. Melting point: 111--112 °C. ^1^H NMR (300 MHz, CDCl~3~): δ 8.86--8.89 (1H, m), 7.84--7.85 (1H, m), 7.69--7.71 (1H, m), 7.42--7.46 (2H, m), 7.31 (1H, t, *J* = 4.8 Hz), 7.17--7.24 (1H, m), 2.40 (3H, s). ^13^C NMR (75 MHz, CDCl~3~): δ 149.7, 144.1, 143.3, 138.1, 137.2, 135.2, 128.8, 128.0, 126.4, 125.1, 124.7, 124.6, 122.0, 21.4. FT-IR (KBr, cm^--1^): 1609, 1580, 1556, 1474, 1430, 1360, 1019, 831, 686. HR-MS (*m*/*z*) for C~14~H~10~BrNS (M^+^): calculated 302.9717, found 302.9713 (one of the major peaks).

### 6-Bromo-8-methyl-4-phenyl-quinoline (**4c**) {#sec4-3-3}

Yield: 78% (233 mg, 0.78 mmol). Characteristic: grey oil. ^1^H NMR (300 MHz, CDCl~3~): δ 8.86--8.89 (1H, m), 7.80--7.83 (1H, m), 7.47--7.52 (1H, m), 7.34--7.45 (5H, m), 7.21--7.24 (1H, m), 2.33 (3H, s). ^13^C NMR (75 MHz, CDCl~3~): δ 149.7, 148.4, 144.2, 137.8, 137.1, 135.1, 129.5, 128.6, 128.5, 128.0, 124.8, 122.2, 21.4. FT-IR (neat, cm^--1^): 1612, 1584, 1570, 1481, 1445, 1431, 1366, 1246, 1032, 863, 763, 701, 620. HR-MS (*m*/*z*) for C~16~H~12~BrN (M^+^): calculated 297.0153, found 297.0157 (one of the major peaks).

### 5,8-Dichloro-4-phenylquinoline (**4d**) {#sec4-3-4}

Yield: 72% (197 mg, 0.72 mmol). Characteristic: yellow oil. ^1^H NMR (300 MHz, CDCl~3~): δ 8.96 (1H, d, *J* = 4.2 Hz), 7.70 (1H, d, *J* = 8.4 Hz), 7.41 (1H, d, *J* = 8.4 Hz), 7.31--7.35 (3H, m), 7.20--7.23 (3H, m). ^13^C NMR (75 MHz, CDCl~3~): δ 149.8, 149.3, 145.7, 140.1, 133.3, 130.1, 129.9, 129.2, 129.2, 128.8, 128.0, 127.8, 125.7, 118.8. FT-IR (neat, cm^--1^): 1645, 1603, 1591, 1563, 1480, 1381, 1178, 1027, 832, 810, 783. HR-MS (*m*/*z*) for C~15~H~9~Cl~2~N (M^+^): calculated 273.0112, found 273.0117 (one of the major peaks).

### 6-Ethyl-4-phenylquinoline (**4e**) {#sec4-3-5}

Yield: 67% (156 mg, 0.67 mmol). Characteristic: brown oil. ^1^H NMR (300 MHz, CDCl~3~): δ 8.78 (1H, d, *J* = 4.5 Hz), 8.01 (1H, d, *J* = 8.7 Hz), 7.59 (1H, s), 7.47--7.52 (1H, m), 7.40--7.44 (5H, m), 7.19--7.22 (1H, m), 2.67 (2H, q, *J* = 7.5 Hz), 1.17 (3H, t, *J* = 7.5 Hz). ^13^C NMR (75 MHz, CDCl~3~): δ 149.0, 147.9, 147.4, 142.8, 138.2, 131.6, 130.4, 129.6, 129.5, 128.5, 128.4, 128.3, 126.7, 123.3, 121.3, 29.1, 15.5. FT-IR (neat, cm^--1^): 1620, 1588, 1561, 1482, 1432, 1379, 1353, 1045, 867, 834, 741, 710. HR-MS (*m*/*z*) for C~17~H~15~N (M^+^): calculated 233.1204, found 233.1203.

### 6-Isopropyl-4-*p*-tolylquinoline (**4f**) {#sec4-3-6}

Yield: 67% (175 mg, 0.67 mmol). Characteristic: yellow oil. ^1^H NMR (300 MHz, CDCl~3~): δ 8.78 (1H, s), 8.03 (1H, d, *J* = 8.7 Hz), 7.66 (1H, s), 7.54 (1H, dd, *J* = 8.7, 1.8 Hz), 7.33 (2H, d, *J* = 7.8 Hz), 7.25 (2H, d, *J* = 8.1 Hz), 7.16--7.19 (1H, m), 2.88--2.97 (1H, m), 2.38 (3H, s), 1.18 (6H, d, *J* = 6.6 Hz). ^13^C NMR (75 MHz, CDCl~3~): δ 143.4, 142.5, 141.8, 141.5, 132.5, 129.6, 124.0, 123.7, 123.6, 123.1, 121.1, 116.4, 115.7, 28.6, 18.2, 15.6. FT-IR (neat, cm^--1^): 1614, 1584, 1569, 1501, 1456, 1384, 1042, 859, 817, 755, 698. HR-MS (*m*/*z*) for C~19~H~19~N (M^+^): calculated 261.1517, found 262.1594 (M^+^ + H).

### 4-(4-Methoxyphenyl)-5,7-dimethylquinoline (**4g**) {#sec4-3-7}

Yield: 80% (210 mg, 0.80 mmol). Characteristic: brown solid. Melting point: 82--83 °C. ^1^H NMR (300 MHz, CDCl~3~): δ 8.70 (1H, d, *J* = 4.5 Hz), 7.75 (1H, s), 7.13 (2H, d, *J* = 8.7 Hz), 7.05 (2H, d, *J* = 3.9 Hz), 6.88 (2H, d, *J* = 8.4 Hz), 3.80 (3H, s), 2.42 (3H, s), 1.94 (3H, s). ^13^C NMR (75 MHz, CDCl~3~): δ 159.3, 149.9, 148.7, 148.4, 138.9, 135.3, 134.7, 132.2, 129.8, 127.4, 124.7, 123.0, 113.3, 55.3, 24.4, 21.4. FT-IR (KBr, cm^--1^): 2970, 1666, 1609, 1571, 1514, 1492, 1457, 1435, 1248, 1032, 832. HR-MS (*m*/*z*) for C~18~H~17~NO (M^+^): calculated 263.1310, found 263.1313.

### 6-Methoxy-4-phenylquinoline (**4h**)^[@ref96]^ {#sec4-3-8}

Yield: 67% (157 mg, 0.67 mmol). Characteristic: brown oil. ^1^H NMR (300 MHz, CDCl~3~): δ 8.80 (1H, d, *J* = 4.5 Hz), 8.08 (1H, d, *J* = 9.3 Hz), 7.52 (5H, s), 7.39 (1H, dd, *J* = 9.3, 2.7 Hz), 7.30 (1H, d, *J* = 4.2 Hz), 7.19 (1H, d, *J* = 2.4 Hz), 3.78 (3H, s). ^13^C NMR (75 MHz, CDCl~3~): δ 157.9, 147.3, 147.2, 144.5, 138.2, 131.0, 129.2, 128.6, 128.3, 127.7, 121.8, 121.6, 103.7, 55.4. FT-IR (KBr, cm^--1^): 2925, 1623, 1584, 1501, 1432, 1248, 1030, 856. HR-MS (*m*/*z*) for C~16~H~13~NO (M^+^): calculated 235.0997, found 235.0996.

### 8-Bromo-4-*m*-tolylquinoline (**4i**) {#sec4-3-9}

Yield: 77% (230 mg, 0.77 mmol). Characteristic: yellow solid. Melting point: 97--98 °C. ^1^H NMR (300 MHz, CDCl~3~): δ 8.90 (1H, d, *J* = 4.5 Hz), 7.90 (1H, d, *J* = 7.5 Hz), 7.74 (1H, d, *J* = 8.4 Hz), 7.22--7.28 (2H, m), 7.10--7.20 (4H, m), 2.30 (3H, s). ^13^C NMR (75 MHz, CDCl~3~): δ 150.6, 149.4, 145.5, 138.4, 137.4, 133.1, 130.1, 129.4, 128.5, 128.3, 126.8, 126.6, 126.1, 125.1, 122.1, 21.4. HR-MS (*m*/*z*) for C~16~H~12~BrN (M^+^): calculated 297.0153, found 297.0152 (one of the major peaks).

### 4-(Biphenyl-4-yl)-8-bromoquinoline (**4j**) {#sec4-3-10}

Yield: 73% (262 mg, 0.73 mmol). Characteristic: brown solid. Melting point: 130--132 °C. ^1^H NMR (300 MHz, CDCl~3~): δ 9.01 (1H, d, *J* = 4.5 Hz), 8.01 (1H, dd, *J* = 7.5, 0.9 Hz), 7.90 (1H, dd, *J* = 8.4, 0.9 Hz), 7.67 (2H, dd, *J* = 8.1, 1.8 Hz), 7.61 (2H, dd, *J* = 8.7, 1.5 Hz), 7.26--7.49 (7H, m). ^13^C NMR (75 MHz, CDCl~3~): δ 150.6, 148.9, 145.6, 141.6, 140.2, 136.4, 133.2, 130.0, 128.9, 128.2, 127.8, 127.3, 127.1, 126.9, 126.0, 125.2, 122.2. FT-IR (KBr, cm^--1^): 1639, 1599, 1579, 1494, 1450, 1405, 839, 763, 734, 714, 698. HR-MS (*m*/*z*) for C~21~H~14~BrN (M^+^): calculated 359.0310, found 359.0306 (one of the major peaks).

### 8-Bromo-4-(6-methoxynaphthalen-2-yl)quinoline (**4k**) {#sec4-3-11}

Yield: 72% (261 mg, 0.72 mmol). Characteristic: brown solid. Melting point: 148--149 °C. ^1^H NMR (300 MHz, CDCl~3~): δ 9.00 (1H, d, *J* = 4.2 Hz), 8.01 (1H, dd, *J* = 7.5, 0.9 Hz), 7.90 (1H, dd, *J* = 8.4, 0.9 Hz), 7.81--7.83 (2H, m), 7.73 (1H, d, *J* = 9.0 Hz), 7.49 (1H, d, *J* = 1.5 Hz), 7.39--7.46 (1H, m), 7.30 (1H, t, *J* = 7.9 Hz), 7.13--7.17 (2H, m), 3.89 (3H, s). ^13^C NMR (75 MHz, CDCl~3~): δ 157.9, 149.9, 149.1, 133.9, 132.7, 131.9, 129.2, 128.0, 127.9, 127.1, 126.6, 126.5, 125.7, 121.9, 119.2, 105.2, 54.9. FT-IR (KBr, cm^--1^): 1625, 1604, 1580, 1492, 1452, 1384, 1252, 1209, 1026, 853, 819, 768, 747. HR-MS (*m*/*z*) for C~20~H~15~BrNO (M^+^ + H): calculated 364.0337, found 364.0334 (M^+^ + H, one of the major peaks).

### 8-Bromo-4-(*o*-tolyloxymethyl)quinoline (**4l**) {#sec4-3-12}

Yield: 65% (212 mg, 0.65 mmol). Characteristic: brown solid. Melting point: 78--79 °C. ^1^H NMR (300 MHz, CDCl~3~): δ 8.97 (1H, d, *J* = 3.6 Hz), 8.00 (1H, d, *J* = 7.5 Hz), 7.88 (1H, d, *J* = 8.4 Hz), 7.59 (1H, d, *J* = 3.3 Hz), 7.35 (1H, t, *J* = 7.5 Hz), 7.09--7.13 (2H, m), 6.85 (2H, t, *J* = 8.4 Hz), 5.44 (2H, s), 2.23 (3H, s). ^13^C NMR (75 MHz, CDCl~3~): δ 156.2, 151.1, 145.1, 143.2, 133.2, 131.1, 127.2, 127.1, 126.9, 125.8, 122.7, 121.3, 120.0, 111.3, 66.4, 16.3. FT-IR (KBr, cm^--1^): 1646, 1601, 1587, 1463, 1368, 1306, 1291, 1191, 1020, 754. HR-MS (*m*/*z*) for C~17~H~14~BrNO (M^+^): calculated 327.0259, found 327.0261 (one of the major peaks).

### 8-Bromo-4-phenylquinoline (**4m**) {#sec4-3-13}

Yield: 75% (212 mg, 0.75 mmol). Characteristic: brown oil. ^1^H NMR (300 MHz, CDCl~3~): δ 8.97--8.98 (1H, m), 7.98 (1H, dd, *J* = 7.2, 4.5 Hz), 7.79 (1H, dd, *J* = 8.1, 1.5 Hz), 7.17--7.46 (7H, m). ^13^C NMR (75 MHz, CDCl~3~): 150.5, 149.3, 145.5, 137.5, 133.2, 129.5, 128.6, 128.2, 126.9, 126.0, 125.1, 122.2. FT-IR (neat, cm^--1^): 1611, 1581, 1490, 1442, 1391, 1372, 779, 751, 731, 702. HR-MS (*m*/*z*) for C~15~H~10~BrN (M^+^): calculated 282.9997, found 282.9994 (one of the major peaks).

### 8-Bromo-4-(4-methoxyphenyl)quinoline (**4n**) {#sec4-3-14}

Yield: 70% (220 mg, 0.70 mmol). Characteristic: brown solid. Melting point: 78--80 °C. ^1^H NMR (300 MHz, CDCl~3~): δ 8.94 (1H, dd, *J* = 4.3, 1.2 Hz), 7.90 (1H, dd, *J* = 7.5, 1.2 Hz), 7.84 (1H, d, *J* = 8.4 Hz), 7.24--7.34 (4H, m), 6.96 (2H, dd, *J* = 9.7, 1.8 Hz), 3.79 (3H, s). ^13^C NMR (75 MHz, CDCl~3~): δ 160.0, 150.5, 149.1, 145.5, 133.1, 130.8, 129.7, 128.4, 126.7, 126.0, 125.0, 122.1, 114.1, 55.4. FT-IR (KBr, cm^--1^): 1666, 1607, 1584, 1513, 1489, 1455, 1386, 1248, 1178, 1037, 837, 766. HR-MS (*m*/*z*) for C~16~H~12~BrNO (M^+^): calculated 313.0102, found 313.0104 (one of the major peaks).

### 8-Bromo-6-methyl-4-phenylquinoline (**4o**) {#sec4-3-15}

Yield: 71% (212 mg, 0.71 mmol). Characteristic: grey oil. ^1^H NMR (300 MHz, CDCl~3~): δ 8.86--8.89 (1H, m), 7.80--7.83 (1H, m), 7.47--7.52 (1H, m), 7.34--7.45 (5H, m), 7.21--7.24 (1H, m), 2.33 (3H, s). ^13^C NMR (75 MHz, CDCl~3~): δ 149.7, 148.4, 144.2, 137.8, 137.1, 135.1, 129.5, 128.6, 128.5, 128.0, 124.8, 122.2, 21.4. FT-IR (neat, cm^--1^): 1612, 1584, 1570, 1481, 1445, 1431, 1366, 1246, 1032, 863, 763, 701, 620. HR-MS (*m*/*z*) for C~16~H~12~BrN (M^+^): calculated 297.0153, found 297.0157 (one of the major peaks).

### 8-Bromo-6-methyl-4-*m*-tolylquinoline (**4p**) {#sec4-3-16}

Yield: 70% (218 mg, 0.70 mmol). Characteristic: yellow solid. Melting point: 126--128 °C. ^1^H NMR (300 MHz, CDCl~3~): δ 8.87 (1H, d, *J* = 4.2 Hz), 7.80 (1H, s), 7.52 (1H, s), 7.30 (1H, t, *J* = 7.5 Hz), 7.19--7.22 (2H, m), 7.13--7.16 (2H, m), 2.34 (3H, s), 2.32 (3H, s). ^13^C NMR (75 MHz, CDCl~3~): δ 149.1, 148.1, 143.6, 137.8, 137.2, 136.5, 134.6, 129.5, 128.7, 127.9, 127.5, 126.1, 124.3, 124.1, 121.7, 20.9. FT-IR (KBr, cm^--1^): 1610, 1603, 1573, 1482, 1468, 1439, 1376, 1364, 1022, 882, 786, 754, 710. HR-MS (*m*/*z*) for C~17~H~15~BrN (M^+^ + H): calculated 312.0388, found 312.0389 (M^+^ + H, one of the major peaks).

### 5,8-Dichloro-4-*m*-tolylquinoline (**4q**) {#sec4-3-17}

Yield: 62% (178 mg, 0.62 mmol). Characteristic: yellow solid. Melting point: 80 °C. ^1^H NMR (300 MHz, CDCl~3~): δ 8.93 (1H, dd, *J* = 3.9, 1.8 Hz), 7.66--7.70 (1H, m), 7.37--7.41 (1H, m), 7.28--7.30 (1H, m), 7.16--7.21 (2H, m), 6.99--7.02 (2H, m), 2.30 (3H, s). ^13^C NMR (75 MHz, CDCl~3~): δ 149.8, 149.4, 145.7, 140.0, 137.4, 133.3, 130.1, 129.9, 129.2, 129.1, 128.7, 127.6, 126.0, 125.8, 118.5, 21.4. FT-IR (KBr, cm^--1^): 1642, 1606, 1589, 1569, 1483, 1383, 1189, 1020, 847, 814, 784. HR-MS (*m*/*z*) for C~16~H~11~Cl~2~N (M^+^): calculated 287.0269, found 287.0271 (one of the major peaks).

### 8-Methyl-4-phenylquinoline (**4r**) {#sec4-3-18}

Yield: 67% (147 mg, 0.67 mmol). Characteristic: brown oil. ^1^H NMR (300 MHz, CDCl~3~): δ 8.85--8.88 (1H, m), 7.65 (1H, d, *J* = 8.4 Hz), 7.43--7.48 (1H, m), 7.37--7.39 (5H, m), 7.15--7.30 (2H, m), 2.76 (3H, s). ^13^C NMR (75 MHz, CDCl~3~): δ 148.6, 147.7, 138.5, 137.3, 129.5, 129.5, 128.4, 128.2, 126.7, 126.2, 123.9, 121.1, 18.6. FT-IR (neat, cm^--1^): 1602, 1582, 1571, 1477, 1432, 1383, 1364, 1055, 867, 839, 735, 711. HR-MS (*m*/*z*) for C~16~H~13~NNa (M^+^ + Na): calculated 242.0946, found 242.0948 (M^+^ + Na).

### 4-*p*-Tolylquinoline (**4s**) {#sec4-3-19}

Yield: 78% (171 mg, 0.78 mmol). Characteristic: blackish oil. ^1^H NMR (300 MHz, CDCl~3~): δ 8.87 (1H, d, *J* = 4.2 Hz), 8.12 (1H, d, *J* = 8.7 Hz), 7.89 (1H, d, *J* = 8.4 Hz), 7.66 (1H, t, *J* = 7.5 Hz), 7.43 (1H, t, *J* = 7.5 Hz), 7.19--7.36 (5H, m), 2.40 (3H, s). ^13^C NMR (75 MHz, CDCl~3~): δ 149.8, 148.7, 148.4, 138.3, 134.9, 129.6, 129.4, 129.3, 129.2, 126.8, 126.5, 125.9, 121.2, 21.2. FT-IR (neat, cm^--1^): 1614, 1586, 1569, 1501, 1460, 1421, 1390, 1276, 1010, 819, 764. HR-MS (*m*/*z*) for C~16~H~13~N (M^+^): calculated 219.1048, found 219.1052.

### 8-Bromo-2-isobutyl-4-*p*-tolylquinoline (**4t**) {#sec4-3-20}

Yield: 70% (247 mg, 0.70 mmol). Characteristic: brown oil. ^1^H NMR (300 MHz, CDCl~3~): 8.05 (1H, d, *J* = 8.4 Hz), 7.82 (1H, d, *J* = 8.1 Hz), 7.60 (1H, t, *J* = 7.5 Hz), 7.30--7.38 (2H, m), 7.24 (2H, d, *J* = 7.8 Hz), 7.16 (1H, s), 2.80 (2H, d, *J* = 7.2 Hz), 2.37 (3H, s), 2.07--2.20 (1H, m), 0.91 (6H, d, *J* = 6.6 Hz). ^13^C NMR (75 MHz, CDCl~3~): δ 161.6, 148.8, 148.0, 138.3, 135.2, 129.4, 129.3, 129.2, 128.9, 125.7, 125.4, 122.2, 48.1, 29.4, 22.6, 21.2. FT-IR (neat, cm^--1^): 1624, 1590, 1573, 1499, 1456, 1344, 1127, 1053, 855, 817, 760, 711, 698. HR-MS (*m*/*z*) for C~20~H~20~BrN (M^+^): calculated 353.0779, found 353.0781 (one of the major peaks).

### 6-Ethyl-2-(4-nitrophenyl)-4-*p*-tolylquinoline (**4u**) {#sec4-3-21}

Yield: 66% (243 mg, 0.66 mmol). Characteristic: grey solid. Melting point: 130--132 °C. ^1^H NMR (300 MHz, CDCl~3~): δ 8.29 (4H, s), 8.09 (1H, d, *J* = 8.7 Hz), 7.73 (1H, s), 7.66 (1H, s), 7.58 (1H, d, *J* = 8.7 Hz), 7.40 (2H, d, *J* = 7.8 Hz), 7.31 (2H, d, *J* = 8.1 Hz), 2.72 (2H, q, *J* = 7.5 Hz), 2.43 (3H, s), 1.21 (3H, t, *J* = 7.5 Hz). ^13^C NMR (75 MHz, CDCl~3~): δ 153.2, 149.2, 148.2, 147.6, 145.6, 143.5, 138.5, 135.2, 131.0, 130.1, 129.3, 128.7, 128.1, 126.2, 123.9, 123.3, 119.0, 21.2, 19.0, 15.4. FT-IR (KBr, cm^--1^): 2960, 2926, 1725, 1595, 1548, 1516, 1492, 1456, 1343, 1110, 847, 821, 699. HR-MS (*m*/*z*) for C~24~H~20~N~2~O~2~ (M^+^): calculated 368.1525, found 368.1529.

### 8-Bromo-2-(2-bromophenyl)-6-methyl-4-phenylquinoline (**4v**) {#sec4-3-22}

Yield: 63% (273 mg, 0.63 mmol). Characteristic: brown oil. ^1^H NMR (300 MHz, CDCl~3~): δ 8.85 (1H, s), 8.38 (1H, dd, *J* = 7.8 Hz), 7.08--8.13 (1H, m), 7.95 (1H, dd, *J* = 7.2 Hz), 7.74--7.82 (2H, m), 7.60--7.66 (1H, m), 7.47 (1H, s), 7.14--7.25 (2H, m), 7.04 (1H, d, *J* = 8.1 Hz), 2.35 (3H, s), 2.16 (3H, s). ^13^C NMR (75 MHz, CDCl~3~): δ 159.5, 157.5, 147.6, 140.1, 137.9, 137.2, 135.3, 135.2, 133.4, 132.4, 131.3, 130.0, 129.6, 128.6, 128.4, 127.7, 126.8, 125.3, 124.4, 123.9, 122.0, 21.4. FT-IR (neat, cm^--1^): 1671, 1587, 1539, 1470, 1433, 1356, 827, 756, 702. HR-MS (*m*/*z*) for C~22~H~15~Br~2~N (M^+^): calculated 450.9571, found 450.9574 (one of the major peaks).

### 8-Bromo-6-methyl-2-(2-nitrophenyl)-4-*m*-tolylquinoline (**4w**) {#sec4-3-23}

Yield: 74% (319 mg, 0.74 mmol). Characteristic: colorless solid. Melting point: 121--122 °C. ^1^H NMR (300 MHz, CDCl~3~): δ 8.85 (1H, s), 8.38 (1H, dd, *J* = 7.8, 1.2 Hz), 8.08--8.13 (1H, m), 7.95 (1H, dd, *J* = 7.5, 1.8 Hz), 7.74--7.82 (2H, m), 7.60--7.66 (1H, m), 7.47 (1H, s), 7.14--7.25 (2H, m), 7.04 (1H, d, *J* = 8.1 Hz), 2.35 (3H, s), 2.16 (3H, s). ^13^C NMR (75 MHz, CDCl~3~): δ 156.7, 147.0, 137.9, 134.0, 133.7, 133.6, 133.4, 132.6, 131.3, 131.0, 130.2, 129.6, 129.1, 128.9, 127.5, 124.5, 119.3, 118.6, 115.7, 20.6, 20.0. FT-IR (KBr, cm^--1^): 1627, 1607, 1571, 1518, 1487, 1337, 1209, 1077, 807, 738. HR-MS (*m*/*z*) for C~23~H~17~BrN~2~O~2~ (M^+^): calculated 432.0473, found 432.0476 (one of the major peaks).

Characterization Data of Chiral Sugar-Based Quinoline Derivatives (**7a--f**) {#sec4-4}
-----------------------------------------------------------------------------

Synthesis of compound **7** was performed according to the procedure for compound **4**.

### (*R*)-2-(2,2-Dimethyl-1,3-dioxolan-4-yl)-6-methoxy-4-phenylquinoline (**7a**) {#sec4-4-1}

Yield: 65% (218.0 mg, 0.65 mmol). Characteristic: black oil. \[α\]~D~^25^ -- 78.40 (*c* 0.18, CHCl~3~). ^1^H NMR (300 MHz, CDCl~3~): δ 8.27 (1H, d, *J* = 9.3 Hz), 7.64 (1H, s), 7.56 (4H, s), 7.46 (1H, d, *J* = 8.4 Hz), 7.26 (1H, d, *J* = 1.5 Hz), 7.22 (1H, s), 4.11 (1H, dd, *J* = 16.0, 7.8 Hz), 3.80 (3H, s), 3.27 (1H, dd, *J* = 12.0, 3.6 Hz), 3.16 (1H, dd, *J* = 12.0, 7.2 Hz), 1.58 (3H, s), 1.52 (3H, s). ^13^C NMR (75 MHz, CDCl~3~): δ 158.5, 156.5, 152.6, 141.7, 137.6, 129.1, 128.9, 128.8, 128.4, 127.5, 123.3, 121.3, 121.3, 118.7, 110.8, 104.1, 70.5, 67.2, 55.7, 26.8, 26.4. FT-IR (neat, cm^--1^): 1713, 1627, 1589, 1496, 1378, 1256, 1210, 1163, 1072, 883, 836, 758, 707. HR-MS (*m*/*z*) for C~21~H~21~NO~3~ (M^+^): calculated 335.1521, found 335.1524.

### 2-((3a*R*,5*R*,6*R*,6a*R*)-6-(Benzyloxy)-2,2-dimethyltetrahydrofuro\[3,2-*d*\]\[1,3\]dioxol-5-yl)-8-bromo-4-*p*-tolylquinoline (**7b**) {#sec4-4-2}

Yield: 68% (371.5 mg, 0.68 mmol). Characteristic: yellow oil. \[α\]~D~^25^ -- 53.70 (*c* 0.20, CHCl~3~). ^1^H NMR (300 MHz, CDCl~3~): δ 8.05 (1H, d, *J* = 7.5 Hz), 7.92 (1H, d, *J* = 8.7 Hz), 7.76 (1H, s), 7.26--7.42 (5H, m), 7.06--7.16 (3H, m), 6.83 (2H, d, *J* = 7.2 Hz), 6.19 (1H, d, *J* = 3.0 Hz), 5.72 (1H, d, *J* = 2.7 Hz), 4.75 (1H, d, *J* = 12.6 Hz), 4.55--4.58 (1H, m), 4.41 (1H, d, *J* = 11.7 Hz), 4.19 (1H, d, *J* = 11.7 Hz), 2.64 (3H, s), 1.61 (3H, s), 1.39 (3H, s). ^13^C NMR (75 MHz, CDCl~3~): δ 158.4, 150.0, 149.7, 145.0, 138.8, 134.4, 132.9, 128.9, 128.8, 128.1, 126.4, 125.8, 124.4, 121.4, 117.9, 112.2, 105.6, 84.1, 83.4, 78.5, 72.7, 26.8, 26.4, 21.2. FT-IR (neat, cm^--1^): 1713, 1631, 1582, 1491, 1451, 1379, 1209, 1084, 1021, 905, 866, 764, 701. HR-MS (*m*/*z*) for C~30~H~28~BrNO~4~ (M^+^): calculated 545.1201, found 545.1204 (one of the major peaks).

### 2-((3a*R*,5*R*,6*S*,6a*R*)-6-(Benzyloxy)-2,2-dimethyltetrahydrofuro\[3,2-*d*\]\[1,3\]dioxol-5-yl)-8-bromo-4-*p*-tolylquinoline (**7c**) {#sec4-4-3}

Yield: 63% (344.0 mg, 0.63 mmol). Characteristic: yellow oil. \[α\]~D~^25^ -- 62.43 (*c* 0.19, CHCl~3~). ^1^H NMR (300 MHz, CDCl~3~): δ 8.03 (1H, d, *J* = 7.2 Hz), 7.91 (1H, d, *J* = 8.4 Hz), 7.75 (1H, s), 7.25--7.40 (5H, m), 7.03--7.14 (3H, m), 6.82 (2H, d, *J* = 7.2 Hz), 6.17 (1H, d, *J* = 3.3 Hz), 5.70 (1H, d, *J* = 3.0 Hz), 4.72 (1H, d, *J* = 3.0 Hz), 4.55 (1H, d, *J* = 3.0 Hz), 4.40 (1H, d, *J* = 11.7 Hz), 4.17 (1H, d, *J* = 12.0 Hz), 2.45 (3H, s), 1.60 (3H, s), 1.38 (3H, s). ^13^C NMR (75 MHz, CDCl~3~): δ 158.3, 149.9, 149.3, 144.7, 138.3, 134.0, 132.8, 128.9, 128.8, 127.8, 126.3, 125.6, 124.2, 121.4, 117.8, 112.2, 105.7, 84.1, 83.4, 78.3, 72.7, 26.7, 26.4, 21.2. FT-IR (neat, cm^--1^): 1712, 1623, 1586, 1489, 1455, 1382, 1217, 1078, 1029, 859, 707. HR-MS (*m*/*z*) for C~30~H~28~BrNO~4~ (M^+^): calculated 545.1201, found 545.1206 (one of the major peaks).

### 2-((3a*R*,5*R*,6*S*,6a*R*)-6-(Benzyloxy)-2,2-dimethyltetrahydrofuro\[3,2-*d*\]\[1,3\]dioxol-5-yl)-5,7-dimethyl-4-phenylquinoline (**7d**) {#sec4-4-4}

Yield: 70% (337.0 mg, 0.70 mmol). Characteristic: yellow oil. \[α\]~D~^25^ -- 59.00 (*c* 0.80, CHCl~3~). ^1^H NMR (300 MHz, CDCl~3~): δ 7.78 (1H, s), 7.50 (1H, s), 7.30--7.40 (5H, m), 7.05--7.15 (4H, m), 6.82 (2H, d, *J* = 7.2 Hz), 6.13 (1H, d, *J* = 3.6 Hz), 5.60 (1H, d, *J* = 3.0 Hz), 4.71 (1H, d, *J* = 3.6 Hz), 4.43 (1H, d, *J* = 3.0 Hz), 4.33 (1H, d, *J* = 11.7 Hz), 4.06 (1H, d, *J* = 11.7 Hz), 2.50 (3H, s), 1.98 (3H, s), 1.57 (3H, s), 1.32 (3H, s). ^13^C NMR (75 MHz, CDCl~3~): δ 155.3, 149.0, 148.7, 142.5, 139.1, 137.3, 135.2, 131.9, 128.8, 128.7, 128.0, 127.2, 126.8, 123.7, 122.0, 112.1, 105.5, 84.0, 83.3, 72.3, 26.9, 26.4, 24.2, 21.3. FT-IR (neat, cm^--1^): 1714, 1621, 1579, 1488, 1453, 1376, 1211, 1082, 1024, 863, 698. HR-MS (*m*/*z*) for C~31~H~31~NO~4~ (M^+^): calculated 481.2253, found 481.2255.

### 8-Bromo-4-phenyl-2-((3a*R*,5*R*,5a*S*,8a*S*,8b*R*)-2,2,7,7-tetramethyltetrahydro-3*aH*-bis\[1,3\]dioxolo\[4,5-*b*:4′,5′-*d*\]pyran-5-yl)quinoline (**7e**) {#sec4-4-5}

Yield: 72% (369.5 mg, 0.72 mmol). Characteristic: brown oil. \[α\]~D~^25^ -- 80.63 (*c* 0.95, CHCl~3~). ^1^H NMR (300 MHz, CDCl~3~): δ 8.00--8.03 (1H, m), 7.83--7.86 (1H, m), 7.73 (1H, d, *J* = 2.7 Hz), 7.49--7.50 (5H, m), 7.41 (1H, d, *J* = 8.1 Hz), 7.26--7.27 (1H, m), 5.78 (1H, d, *J* = 4.8 Hz), 5.28 (1H, s), 5.00 (1H, d, *J* = 7.8 Hz), 4.81--4.83 (1H, m), 4.46 (1H, dd, *J* = 2.7, 2.1 Hz), 1.63 (3H, s), 1.50 (3H, s), 1.40 (3H, s), 1.31 (3H, s). ^13^C NMR (75 MHz, CDCl~3~): δ 159.2, 148.7, 144.9, 144.8, 138.2, 132.7, 132.4, 129.6, 128.4, 128.3, 127.4, 126.2, 125.7, 120.7, 117.9, 109.4, 108.8, 96.7, 73.6, 71.5, 71.0, 70.9, 26.2, 25.9, 24.9, 24.2. FT-IR (neat, cm^--1^): 1712, 1634, 1600, 1508, 1453, 1382, 1255, 1211, 1166, 1068, 1003, 905, 764, 702. HR-MS (*m*/*z*) for C~26~H~26~BrNO~5~ (M^+^): calculated 511.0994, found 511.0997 (one of the major peaks).

### 6-Methoxy-4-phenyl-2-((3a*R*,5*R*,5a*S*,8a*S*,8b*R*)-2,2,7,7-tetramethyltetrahydro-3a*H*-bis\[1,3\]dioxolo\[4,5-*b*:4′,5′-*d*\]pyran-5-yl)quinoline (**7f**) {#sec4-4-6}

Yield: 67% (310.5 mg, 0.67 mmol). Characteristic: yellow oil. \[α\]~D~^25^ -- 56.70 (*c* 1.2, CHCl~3~). ^1^H NMR (300 MHz, CDCl~3~): δ 8.00 (1H, dd, *J* = 7.5, 1.5 Hz), 7.59 (1H, d, *J* = 1.5 Hz), 7.44--7.55 (5H, m), 7.31--7.36 (1H, m), 7.17--7.18 (1H, m), 5.74--5.75 (1H, m), 5.18 (1H, s), 4.84 (1H, dd, *J* = 6.3, 1.5 Hz), 4.76 (1H, dd, *J* = 5.7, 2.1 Hz), 4.41--4.44 (1H, m), 3.75 (3H, s), 1.60 (3H, s), 1.41 (3H, s), 1.37 (3H, s), 1.28 (3H, s). ^13^C NMR (75 MHz, CDCl~3~): δ 157.5, 155.7, 146.9, 143.7, 138.8, 130.6, 129.3, 128.4, 128.0, 126.9, 121.4, 120.4, 109.1, 108.8, 103.7, 96.7, 73.6, 71.0, 70.7, 55.3, 26.2, 25.9, 24.9, 24.2. FT-IR (neat, cm^--1^): 1713, 1622, 1593, 1560, 1493, 1381, 1255, 1214, 1166, 1068, 1012, 889, 833, 760. HR-MS (*m*/*z*) for C~27~H~29~NO~6~ (M^+^): calculated 463.1994, found 463.1992.
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